Skip to main content
. 2023 Nov 21;15(23):5505. doi: 10.3390/cancers15235505

Figure 1.

Figure 1

Therapeutic algorithm for second-line metastatic non-oncogene addicted NSCLC. AA = anti angiogenic agents; ADCs = antibody drugs conjugates; ChT = chemotherapy, IO = immunotherapy; ChT = chemotherapy, irAE = immune-related adverse event; mono= monotherapy; NSCLC = non-small cell lung cancer; PD = progression disease; PFS = progression free survival.